Bian Xiao believes that therapeutic cloning technology is a cell replication technology. Since the birth of Dolly the cloned sheep, people have begun to understand the word cloning. At that time, scientists all over the world were cloning, and this topic was being discussed and debated. Some scientists support cloning technology. They think that cloning is another great progress in human history. They can use cloning technology to improve varieties and enrich people's material life. Let the breeding cost become lower and the efficiency become higher. Cloning technology can also improve the yield of crops and cultivate a large number of crops with disease resistance and insect resistance, thus greatly improving the production quality of crops.

Some scientists are against cloning technology. They believe that cloning technology will lead to gene replication. People's genes were originally diverse, but after using cloning technology, they became one. From complexity to simplicity, this is very unfavorable to people's lives in the future. When people use cloning technology to produce cloned people, it will destroy the self-discipline of biological evolution. Cloning technology will reduce gene variation, interfere with the evolution process and laws of nature, and cause chaos in nature. Cloning technology is not 100% successful, its failure rate is high and its cost is very expensive.

Therapeutic cloning technology is used for stem cell therapy instead of obtaining cloned individuals. Therapeutic cloning technology is to obtain early human embryos and extract pluripotent embryonic stem cells. When doctors get these cells, they will be used in medical technology. Stem cells are called in the medical field? Universal cell? Has the function of regenerating various tissues and organs. At present, therapeutic cloning technology is supported all over the world.

Ok, Bian Xiao will take you here today. I believe everyone has different opinions. If you have anything to share with us, you can leave a message at the bottom of the comments section.